These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1723784

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intratypic variation of herpes simplex virus type 2 isolates detected by monoclonal antibodies against viral glycoproteins.
    Bhattarakosol P, Yoosook C, Cross A.
    Arch Virol; 1990; 115(1-2):89-100. PubMed ID: 1701081
    [Abstract] [Full Text] [Related]

  • 3. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
    Highlander SL, Sutherland SL, Gage PJ, Johnson DC, Levine M, Glorioso JC.
    J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H.
    Gompels UA, Carss AL, Saxby C, Hancock DC, Forrester A, Minson AC.
    J Virol; 1991 May; 65(5):2393-401. PubMed ID: 1707982
    [Abstract] [Full Text] [Related]

  • 6. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
    Krawczyk A, Krauss J, Eis-Hübinger AM, Däumer MP, Schwarzenbacher R, Dittmer U, Schneweis KE, Jäger D, Roggendorf M, Arndt MA.
    J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
    [Abstract] [Full Text] [Related]

  • 7. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
    Sanchez-Pescador L, Paz P, Navarro D, Pereira L, Kohl S.
    J Infect Dis; 1992 Sep; 166(3):623-7. PubMed ID: 1380051
    [Abstract] [Full Text] [Related]

  • 8. Prevention of herpes keratitis by monoclonal antibodies specific for discontinuous and continuous epitopes on glycoprotein D.
    Lousch RN, Staats H, Oakes JE, Cohen GH, Eisenberg RJ.
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2735-40. PubMed ID: 1716618
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M, Petríková M, Zatovicová M, Soláriková L, Kostolanský F, Mucha V, Russ G.
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701403
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibodies directed against a 130K glycoprotein of bovine herpesvirus 2 cross-react with glycoprotein B of herpes simplex virus.
    Conraths FJ, Pauli G, Ludwig H.
    Virus Res; 1988 Apr 01; 10(1):53-63. PubMed ID: 2837013
    [Abstract] [Full Text] [Related]

  • 12. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
    Cairns TM, Shaner MS, Zuo Y, Ponce-de-Leon M, Baribaud I, Eisenberg RJ, Cohen GH, Whitbeck JC.
    J Virol; 2006 Mar 01; 80(6):2596-608. PubMed ID: 16501070
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM, Huang ZY, Gallagher JR, Lin Y, Lou H, Whitbeck JC, Wald A, Cohen GH, Eisenberg RJ.
    J Virol; 2015 Sep 01; 89(18):9213-31. PubMed ID: 26109729
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration.
    Highlander SL, Cai WH, Person S, Levine M, Glorioso JC.
    J Virol; 1988 Jun 01; 62(6):1881-8. PubMed ID: 2452895
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Computer predictions of antigenic domains in herpes simplex virus types 1 and 2 glycoprotein D as compared with experimentally proven domains.
    Becker Y.
    Virus Genes; 1991 Oct 01; 5(4):367-75. PubMed ID: 1724582
    [Abstract] [Full Text] [Related]

  • 20. Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice.
    Geerligs HJ, Kocken CH, Drijfhout JW, Weijer WJ, Bloemhoff W, Wilterdink JB, Welling GW, Welling-Wester S.
    J Gen Virol; 1990 Aug 01; 71 ( Pt 8)():1767-74. PubMed ID: 2167930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.